Logo image of CMPR

CIMPRESS PLC (CMPR) Stock Fundamental Analysis

NASDAQ:CMPR - Nasdaq - IE00BKYC3F77 - Common Stock - Currency: USD

47.74  -1.52 (-3.09%)

After market: 47.74 0 (0%)

Fundamental Rating

4

CMPR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 84 industry peers in the Commercial Services & Supplies industry. While CMPR is still in line with the averages on profitability rating, there are concerns on its financial health. CMPR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CMPR was profitable.
In the past year CMPR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CMPR reported negative net income in multiple years.
In the past 5 years CMPR always reported a positive cash flow from operatings.
CMPR Yearly Net Income VS EBIT VS OCF VS FCFCMPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

With a decent Return On Assets value of 8.27%, CMPR is doing good in the industry, outperforming 78.31% of the companies in the same industry.
CMPR has a better Return On Invested Capital (15.20%) than 87.95% of its industry peers.
CMPR had an Average Return On Invested Capital over the past 3 years of 8.68%. This is below the industry average of 11.67%.
The 3 year average ROIC (8.68%) for CMPR is below the current ROIC(15.20%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.27%
ROE N/A
ROIC 15.2%
ROA(3y)-1.12%
ROA(5y)-0.53%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.68%
ROIC(5y)8.7%
CMPR Yearly ROA, ROE, ROICCMPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

The Profit Margin of CMPR (4.61%) is better than 63.86% of its industry peers.
In the last couple of years the Profit Margin of CMPR has grown nicely.
CMPR has a Operating Margin (6.85%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CMPR has grown nicely.
CMPR's Gross Margin of 47.91% is amongst the best of the industry. CMPR outperforms 86.75% of its industry peers.
In the last couple of years the Gross Margin of CMPR has remained more or less at the same level.
Industry RankSector Rank
OM 6.85%
PM (TTM) 4.61%
GM 47.91%
OM growth 3Y10.14%
OM growth 5Y2.48%
PM growth 3YN/A
PM growth 5Y8.82%
GM growth 3Y-0.7%
GM growth 5Y-0.23%
CMPR Yearly Profit, Operating, Gross MarginsCMPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CMPR is creating value.
The number of shares outstanding for CMPR has been reduced compared to 1 year ago.
CMPR has less shares outstanding than it did 5 years ago.
CMPR has a better debt/assets ratio than last year.
CMPR Yearly Shares OutstandingCMPR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CMPR Yearly Total Debt VS Total AssetsCMPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 2.54 indicates that CMPR is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of CMPR (2.54) is comparable to the rest of the industry.
The Debt to FCF ratio of CMPR is 9.29, which is on the high side as it means it would take CMPR, 9.29 years of fcf income to pay off all of its debts.
CMPR has a Debt to FCF ratio of 9.29. This is comparable to the rest of the industry: CMPR outperforms 57.83% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 9.29
Altman-Z 2.54
ROIC/WACC2.16
WACC7.05%
CMPR Yearly LT Debt VS Equity VS FCFCMPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

CMPR has a Current Ratio of 0.65. This is a bad value and indicates that CMPR is not financially healthy enough and could expect problems in meeting its short term obligations.
CMPR has a Current ratio of 0.65. This is amonst the worse of the industry: CMPR underperforms 89.16% of its industry peers.
CMPR has a Quick Ratio of 0.65. This is a bad value and indicates that CMPR is not financially healthy enough and could expect problems in meeting its short term obligations.
CMPR has a Quick ratio of 0.50. This is amonst the worse of the industry: CMPR underperforms 91.57% of its industry peers.
Industry RankSector Rank
Current Ratio 0.65
Quick Ratio 0.5
CMPR Yearly Current Assets VS Current LiabilitesCMPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

CMPR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 82.55%, which is quite impressive.
The Earnings Per Share has been growing by 16.69% on average over the past years. This is quite good.
CMPR shows a small growth in Revenue. In the last year, the Revenue has grown by 3.64%.
Measured over the past years, CMPR shows a small growth in Revenue. The Revenue has been growing by 3.65% on average per year.
EPS 1Y (TTM)82.55%
EPS 3YN/A
EPS 5Y16.69%
EPS Q2Q%-120%
Revenue 1Y (TTM)3.64%
Revenue growth 3Y8.52%
Revenue growth 5Y3.65%
Sales Q2Q%1.14%

3.2 Future

The Earnings Per Share is expected to decrease by -23.85% on average over the next years. This is quite bad
The Revenue is expected to grow by 3.02% on average over the next years.
EPS Next Y-60.79%
EPS Next 2Y-33.49%
EPS Next 3Y-23.85%
EPS Next 5YN/A
Revenue Next Year2.59%
Revenue Next 2Y2.88%
Revenue Next 3Y3.02%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CMPR Yearly Revenue VS EstimatesCMPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CMPR Yearly EPS VS EstimatesCMPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 -5

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 8.15 indicates a reasonable valuation of CMPR.
Compared to the rest of the industry, the Price/Earnings ratio of CMPR indicates a rather cheap valuation: CMPR is cheaper than 89.16% of the companies listed in the same industry.
CMPR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.30.
A Price/Forward Earnings ratio of 16.63 indicates a correct valuation of CMPR.
CMPR's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CMPR is cheaper than 69.88% of the companies in the same industry.
CMPR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.15
Fwd PE 16.63
CMPR Price Earnings VS Forward Price EarningsCMPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CMPR is valued cheaply inside the industry as 83.13% of the companies are valued more expensively.
93.98% of the companies in the same industry are more expensive than CMPR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 6.81
EV/EBITDA 7.07
CMPR Per share dataCMPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100

4.3 Compensation for Growth

The decent profitability rating of CMPR may justify a higher PE ratio.
A cheap valuation may be justified as CMPR's earnings are expected to decrease with -23.85% in the coming years.
PEG (NY)N/A
PEG (5Y)0.49
EPS Next 2Y-33.49%
EPS Next 3Y-23.85%

0

5. Dividend

5.1 Amount

CMPR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CIMPRESS PLC

NASDAQ:CMPR (7/11/2025, 8:01:06 PM)

After market: 47.74 0 (0%)

47.74

-1.52 (-3.09%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners83.74%
Inst Owner Change0%
Ins Owners9.8%
Ins Owner Change10.35%
Market Cap1.19B
Analysts85
Price Target63.75 (33.54%)
Short Float %8.52%
Short Ratio7.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-81.8%
Min EPS beat(2)-158.82%
Max EPS beat(2)-4.78%
EPS beat(4)1
Avg EPS beat(4)-0.5%
Min EPS beat(4)-269.03%
Max EPS beat(4)430.64%
EPS beat(8)4
Avg EPS beat(8)42.6%
EPS beat(12)5
Avg EPS beat(12)-17.51%
EPS beat(16)7
Avg EPS beat(16)-24.77%
Revenue beat(2)0
Avg Revenue beat(2)-3.72%
Min Revenue beat(2)-4.43%
Max Revenue beat(2)-3.01%
Revenue beat(4)0
Avg Revenue beat(4)-2.65%
Min Revenue beat(4)-4.43%
Max Revenue beat(4)-1.22%
Revenue beat(8)1
Avg Revenue beat(8)-2.22%
Revenue beat(12)3
Avg Revenue beat(12)-1.96%
Revenue beat(16)5
Avg Revenue beat(16)-1.41%
PT rev (1m)0%
PT rev (3m)-31.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.97%
EPS NY rev (1m)-18.86%
EPS NY rev (3m)-30.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.52%
Valuation
Industry RankSector Rank
PE 8.15
Fwd PE 16.63
P/S 0.35
P/FCF 6.81
P/OCF 3.76
P/B N/A
P/tB N/A
EV/EBITDA 7.07
EPS(TTM)5.86
EY12.27%
EPS(NY)2.87
Fwd EY6.01%
FCF(TTM)7.01
FCFY14.69%
OCF(TTM)12.69
OCFY26.58%
SpS135.3
BVpS-22.41
TBVpS-60.63
PEG (NY)N/A
PEG (5Y)0.49
Profitability
Industry RankSector Rank
ROA 8.27%
ROE N/A
ROCE 19.24%
ROIC 15.2%
ROICexc 17.94%
ROICexgc 281.28%
OM 6.85%
PM (TTM) 4.61%
GM 47.91%
FCFM 5.18%
ROA(3y)-1.12%
ROA(5y)-0.53%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.68%
ROIC(5y)8.7%
ROICexc(3y)10.44%
ROICexc(5y)10.24%
ROICexgc(3y)164.51%
ROICexgc(5y)116.75%
ROCE(3y)10.99%
ROCE(5y)11.01%
ROICexcg growth 3Y76.95%
ROICexcg growth 5Y40.7%
ROICexc growth 3Y26.5%
ROICexc growth 5Y11.72%
OM growth 3Y10.14%
OM growth 5Y2.48%
PM growth 3YN/A
PM growth 5Y8.82%
GM growth 3Y-0.7%
GM growth 5Y-0.23%
F-Score6
Asset Turnover1.79
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 9.29
Debt/EBITDA 4.32
Cap/Depr 100.37%
Cap/Sales 4.2%
Interest Coverage 1.74
Cash Conversion 85.01%
Profit Quality 112.36%
Current Ratio 0.65
Quick Ratio 0.5
Altman-Z 2.54
F-Score6
WACC7.05%
ROIC/WACC2.16
Cap/Depr(3y)70.41%
Cap/Depr(5y)64.99%
Cap/Sales(3y)3.73%
Cap/Sales(5y)3.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.55%
EPS 3YN/A
EPS 5Y16.69%
EPS Q2Q%-120%
EPS Next Y-60.79%
EPS Next 2Y-33.49%
EPS Next 3Y-23.85%
EPS Next 5YN/A
Revenue 1Y (TTM)3.64%
Revenue growth 3Y8.52%
Revenue growth 5Y3.65%
Sales Q2Q%1.14%
Revenue Next Year2.59%
Revenue Next 2Y2.88%
Revenue Next 3Y3.02%
Revenue Next 5YN/A
EBIT growth 1Y-4.5%
EBIT growth 3Y19.53%
EBIT growth 5Y6.22%
EBIT Next Year76.63%
EBIT Next 3Y21.6%
EBIT Next 5YN/A
FCF growth 1Y268.84%
FCF growth 3Y12.75%
FCF growth 5Y2.32%
OCF growth 1Y101.98%
OCF growth 3Y9.76%
OCF growth 5Y1.16%